|
original article |
Date |
Title |
Authors All Authors |
1 |
[GO] |
2023―Oct―02 |
A retrospective multicenter cohort study of the association between anti-Factor Xa values and death, thromboembolism, and bleeding in patients with critical COVID-19 |
Sandra Jonmarker, Jacob Litorell, Felix Alarcon, Kais Al-Abani, Sofia Björkman, Maria Farm, et al. (+10) Jonathan Grip, Mårten Söderberg, Jacob Hollenberg, Rebecka Rubenson Wahlin, Thomas Kander, Liivi Rimling, Johan Mårtensson, Eva Joelsson-Alm, Martin Dahlberg, Maria Cronhjort |
2 |
[GO] |
2023―Sep―07 |
A case report of spontaneous pectoral hematoma in a male with background antiplatelet therapy after severe COVID-19 infection |
Hao Tang, Yan Yan |
3 |
[GO] |
2023―Sep―06 |
Incidence of anti-platelet factor4/polyanionic antibodies, thrombocytopenia, and thrombosis after COVID-19 vaccination with ChAdOx1 nCoV-19 in Thais |
Kochawan Boonyawat, Tichayapa Phojanasenee, Phichchapha Noikongdee, Pornnapa Police, Pichika Chantrathammachart, Pimjai Niparuck, et al. (+3) Teeraya Puavilai, Angsana Phuphuakrat, Pantep Angchaisuksiri |
4 |
[GO] |
2023―Aug―23 |
Correction: Predictors of pulmonary embolism in hospitalized patients with COVID-19 |
Jeeyune Bahk, Abdul Rehman, Kam Sing Ho, Bharat Narasimhan, Hafiza Noor Ul Ain Baloch, Jiafang Zhang, et al. (+3) Rowena Yip, Robert Lookstein, David J Steiger |
5 |
[GO] |
2023―Jul―28 |
Coagulation biomarkers and coronavirus disease 2019 phenotyping: a prospective cohort study |
Emily Corneo, Rafael Garbelotto, Gabriele Prestes, Carolina Saibro Girardi, Lucas Santos, Jose Claudio Fonseca Moreira, et al. (+6) Daniel Pens Gelain, Glauco A. Westphal, Emil Kupek, Roger Walz, Cristiane Ritter, Felipe Dal-Pizzol |
6 |
[GO] |
2023―Jul―03 |
Predictors of pulmonary embolism in hospitalized patients with COVID-19 |
Jeeyune Bahk, Abdul Rehman, Kam Sing Ho, Bharat Narasimhan, Hafiza Noor Ul, Ain Baloch, et al. (+4) Jiafang Zhang, Rowena Yip, Robert Lookstein, David J Steiger |
7 |
[GO] |
2023―May―25 |
Clinical characteristics of COVID-19 associated vasculopathic diseases |
Thiemo Greistorfer, Philipp Jud |
8 |
[GO] |
2023―May―02 |
How to exclude pulmonary embolism in patients hospitalized with COVID-19: a comparison of predictive scores |
Jakob Vielhauer, Christopher Benesch, Anna Pernpruner, Anna-Lena Johlke, Johannes Christian Hellmuth, Maximilian Muenchhoff, et al. (+7) Clemens Scherer, Nicola Fink, Bastian Sabel, Christian Schulz, Julia Mayerle, Ujjwal Mukund Mahajan, Hans Christian Stubbe |
9 |
[GO] |
2023―Apr―18 |
Anticoagulation strategy and safety in critically ill COVID-19 patients: a French retrospective multicentre study |
Pauline Lamouche-Wilquin, Léa Perrin, Morgane Pere, Matthieu Raymond, Pierre Asfar, Cedric Darreau, et al. (+14) Florian Reizine, Gwenhaël Colin, Agathe Delbove, Johann Auchabie, Baptiste Hourmant, Aurélien Frérou, Béatrice La Combe, Jean Morin, Pierre Kergoat, Julien Lorber, Pierre-Yves Egreteau, Jérome Souchard, Emmanuel Canet, Jean-Baptiste Lascarrou |
10 |
[GO] |
2023―Jan―30 |
Low dose ultra-slow infusion thrombolytic therapy (LDUSITT) as an alternative option in a COVID-19 patient with free-floating right atrial thrombus: a case report and review of literature |
Mahsa Mahjani, Sepehr Gohari, Hassan Ahangar |
11 |
[GO] |
2023―Jan―30 |
Chronic anti-coagulation therapy reduced mortality in patients with high cardiovascular risk early in COVID-19 pandemic |
Mohamed S. Zaghloul, Momodou Jammeh, Andrew Gibson, Suhong Luo, Kelley Chadwick-Mansker, Qianjin Liu, et al. (+2) Yan Yan, Mohamed A. Zayed |
12 |
[GO] |
2023―Jan―02 |
A snake venom-analog peptide that inhibits SARS-CoV-2 and papain-like protease displays antithrombotic activity in mice arterial thrombosis model, without interfering with bleeding time |
Ruben Siedlarczyk Nogueira, Bruno Ramos Salu, Vinícius Goulart Nardelli, Camila Ramalho Bonturi, Marina Rodrigues Pereira, Francisco Humberto de Abreu Maffei, et al. (+2) Eduardo Maffud Cilli, Maria Luiza Vilela Oliva |
13 |
[GO] |
2022―Dec―08 |
Standard dosing of enoxaparin versus unfractionated heparin in critically ill patient with COVID-19: a multicenter propensity-score matched study |
Khalid Al Sulaiman, Ohoud Aljuhani, Ghazwa B. Korayem, Awatif Hafiz, Mai Alalawi, Hisham A. Badreldin, et al. (+15) Ali F. Altebainawi, Ramesh Vishwakarma, Abdulrahman Alissa, Albandari Alghamdi, Abeer A. Alenazi, Huda Al Enazi, Shahad Alanazi, Abdullah Alhammad, Jahad Alghamdi, Mashael AlFaifi, Faisal A. Al Sehli, Maram A. Aldossari, Alaa A. Alhubaishi, Anfal Y. Al-Ali, Hasan M. Al-Dorzi |
14 |
[GO] |
2022―Sep―26 |
The potential impact of Covid-19 on the capacity of routine laboratory tests to detect heparin-induced thrombocytopenia |
Dominik F. Draxler, Justine Brodard, Björn Zante, Stephan M. Jakob, Jan Wiegand, Johanna A. Kremer Hovinga, et al. (+2) Anne Angelillo-Scherrer, Alicia Rovo |
15 |
[GO] |
2022―Sep―20 |
Incidence, risk factors, and clinical impact of major bleeding in hospitalized patients with COVID-19: a sub-analysis of the CLOT-COVID Study |
Junichi Nakamura, Ichizo Tsujino, Sen Yachi, Makoto Takeyama, Yuji Nishimoto, Satoshi Konno, et al. (+18) Naoto Yamamoto, Hiroko Nakata, Satoshi Ikeda, Michihisa Umetsu, Shizu Aikawa, Hiroya Hayashi, Hirono Satokawa, Yoshinori Okuno, Eriko Iwata, Yoshito Ogihara, Nobutaka Ikeda, Akane Kondo, Takehisa Iwai, Norikazu Yamada, Tomohiro Ogawa, Takao Kobayashi, Makoto Mo, Yugo Yamashita |
16 |
[GO] |
2022―Sep―13 |
Correction: Pulmonary embolism in a patient with eltrombopag-treated aplastic anaemia and paroxysmal nocturnal haemoglobinuria clone during COVID-19 pneumonia |
Alessandro Bosi, Wilma Barcellini, Bruno Fattizo |
17 |
[GO] |
2022―Aug―29 |
Predictive ability of viscoelastic testing using ClotPro® for short-term outcome in patients with severe Covid-19 ARDS with or without ECMO therapy: a retrospective study |
Lars Heubner, Marvin Greiner, Oliver Vicent, Jan Beyer-Westendorf, Oliver Tiebel, Ute Scholz, et al. (+5) Andreas Güldner, Martin Mirus, Dietmar Fries, Thea Koch, Peter Markus Spieth |
18 |
[GO] |
2022―Aug―23 |
Effect of therapeutic versus prophylactic anticoagulation therapy on clinical outcomes in COVID-19 patients: a systematic review with an updated meta-analysis |
Hong Duo, Yahui Li, Yujie Sun, Liang Wei, Ziqing Wang, Fang Fang, et al. (+5) Yuxin Zhong, Jiao Huang, Linjie Luo, Zhiyong Peng, Huaqin Pan |
19 |
[GO] |
2022―Aug―23 |
Pulmonary embolism in a patient with eltrombopag-treated aplastic anaemia and paroxysmal nocturnal haemoglobinuria clone during COVID-19 pneumonia |
Bosi Alessandro, Barcellini Wilma, Fattizzo Bruno |
20 |
[GO] |
2022―Aug―22 |
Very severe immune thrombocytopenia following SARS-CoV-2 vaccination requiring splenectomy: a case report |
Marc Weiner, Robert Rodriguez-Vigouroux, Stavroula Masouridi-Levrat, Kaveh Samii |
21 |
[GO] |
2022―Jun―20 |
Effect of heparin treatment on pulmonary embolism and in-hospital death in unvaccinated COVID-19 patients without overt deep vein thrombosis |
Bruno Bais, Emanuela Sozio, Daniele De Silvestri, Stefano Volpetti, Maria Elena Zannier, Carla Filì, et al. (+12) Flavio Bassi, Lucia Alcaro, Marco Cotrufo, Alberto Pagotto, Alessandro Giacinta, Vincenzo Patruno, Andrea Da Porto, Rodolfo Sbrojavacca, Francesco Curcio, Carlo Tascini, Leonardo Alberto Sechi, GianLuca Colussi |
22 |
[GO] |
2022―May―10 |
Comparison of deep vein thrombosis risks in acute respiratory distress syndrome caused by COVID-19 and bacterial pneumonia: a retrospective cohort study |
Na Cui, Chunguo Jiang, Chenlu Yang, Liming Zhang, Xiaokai Feng |
23 |
[GO] |
2022―Mar―30 |
NETosis and SARS-COV-2 infection related thrombosis: a narrative review |
Mahin Behzadifard, Masoud Soleimani |
24 |
[GO] |
2022―Feb―14 |
The evolution of clot strength in critically ill COVID-19 patients: a prospective observational thromboelastography study |
Syed Nabeel Muzaffar, Suhail Sarwar Siddiqui, Nilanchal Chakraborty, Afzal Azim |
25 |
[GO] |
2021―Dec―20 |
Incidence and characteristics of arterial thromboemboli in patients with COVID-19 |
Nancy Glober, Lauren Stewart, JangDong Seo, Christopher Kabrhel, Kristen Nordenholz, Carlos Camargo, Jeffrey Kline |
26 |
[GO] |
2021―Dec―15 |
Differences between surviving and non-surviving venous thromboembolism COVID-19 patients: a systematic review |
Mauricio Castillo-Perez, Carlos Jerjes-Sanchez, Alejandra Castro-Varela, Jose Gildardo Paredes-Vazquez, Eduardo Vazquez-Garza, Ray Erick Ramos-Cazares, et al. (+10) Jose Alfredo Salinas-Casanova, Abigail Montserrat Molina-Rodriguez, Arturo Adrián Martinez-Ibarra, Mario Alejandro Fabiani, Yoezer Z Flores-Sayavedra, Jaime Alberto Guajardo-Lozano, Hector Lopez-de la Garza, Hector Betancourt-del Campo, Daniela Martinez-Magallanes, Jathniel Panneflek |
27 |
[GO] |
2021―Nov―24 |
Intermediate-to-therapeutic versus prophylactic anticoagulation for coagulopathy in hospitalized COVID-19 patients: a systemic review and meta-analysis |
Sirui Zhang, Yupei Li, Guina Liu, Baihai Su |
28 |
[GO] |
2021―Nov―15 |
Standard- versus intermediate-dose enoxaparin for anti-factor Xa guided thromboprophylaxis in critically ill patients with COVID-19 |
David Oliver Hamilton, Alexander Main-Ian, Jessie Tebbutt, Maya Thrasher, Alicia Waite, Ingeborg Welters |
29 |
[GO] |
2021―Nov―13 |
Thromboembolic and hemorrhagic risks after vaccination against SARS-CoV-2: a systematic review and meta-analysis of randomized controlled trials |
Noppacharn Uaprasert, Krissana Panrong, Ponlapat Rojnuckarin, Thita Chiasakul |
30 |
[GO] |
2021―Nov―06 |
The evolution of clot strength in critically-ill COVID-19 patients: a prospective observational thromboelastography study |
Colette Neethling, Gregory Calligaro, Malcolm Miller, Jessica J. S. Opie |
31 |
[GO] |
2021―Nov―04 |
Low FXIII activity levels in intensive care unit hospitalized COVID-19 patients |
Yael Lichter, Tanya Badelbayov, Irina Shalev, Reut Schvartz, Yishay Szekely, Dan Benisty, et al. (+9) Ilana Goldiner, Maxim Kagarlyk, Keren Asraf, Ram Doolman, Efrat Luttwak, Ilya Kirgner, Irit Avivi, Nimrod Adi, Ben-Zion Katz |
32 |
[GO] |
2021―Sep―16 |
Risk of heparinoid use in cosmetics and moisturizers in individuals vaccinated against severe acute respiratory syndrome coronavirus 2 |
Kenji Yamamoto |
33 |
[GO] |
2021―Aug―23 |
Thrombosis in COVID-19 infection: Role of platelet activation-mediated immunity |
Mahin Behzadi Fard, Samaneh Behzadi Fard, Shahin Ramazi, Amir Atashi, Zahra Eslamifar |
34 |
[GO] |
2021―Aug―18 |
Multiple simultaneous embolic cerebral infarctions 11 months after COVID-19 |
Rajiv Advani, Torbjørn Austveg Strømsnes, Espen Stjernstrøm, Sebastian T. Lugg |
35 |
[GO] |
2021―Aug―16 |
Temporal change in Syndecan-1 as a therapeutic target and a biomarker for the severity classification of COVID-19 |
Fumihiro Ogawa, Yasufumi Oi, Kento Nakajima, Reo Matsumura, Tomoki Nakagawa, Takao Miyagawa, et al. (+8) Kazuya Sakai, Ryo Saji, Hayato Taniguchi, Kohei Takahashi, Takeru Abe, Masayuki Iwashita, Mototsugu Nishii, Ichiro Takeuchi |
36 |
[GO] |
2021―Jun―29 |
A review of thromboembolic events in hospitalized COVID-19 patients |
Paul Fontelo, Mrigendra M. Bastola, Zhaonian Zheng, Seo Hyon Baik |
37 |
[GO] |
2021―Jun―02 |
Point of care diagnostic of hypercoagulability and platelet function in COVID-19 induced acute respiratory distress syndrome: a retrospective observational study |
Johannes Herrmann, Quirin Notz, Tobias Schlesinger, Jan Stumpner, Markus Kredel, Magdalena Sitter, et al. (+5) Benedikt Schmid, Peter Kranke, Harald Schulze, Patrick Meybohm, Christopher Lotz |
38 |
[GO] |
2021―Jun―02 |
Point of care ultrasound screening for deep vein thrombosis in critically ill COVID-19 patients, an observational study |
Sarah Galien, Michael Hultström, Miklós Lipcsey, Karl Stattin, Robert Frithiof, Jacob Rosén, et al. (+5) Tomas Luther, Sara Bülow Anderberg, Anna Gradin, Sten Rubertsson, Katja Hanslin |
39 |
[GO] |
2021―May―31 |
Serial markers of coagulation and inflammation and the occurrence of clinical pulmonary thromboembolism in mechanically ventilated patients with SARS-CoV-2 infection; the prospective Maastricht intensive care COVID cohort |
Mark M. G. Mulder, LIoyd Brandts, Renée A. G. Brüggemann, Marcel Koelmann, Alexander S. Streng, Renske H. Olie, et al. (+10) Hester A. Gietema, Henri M. H. Spronk, Iwan C. C. van der Horst, Jan-Willem E. M. Sels, Joachim E. Wildberger, Sander M. J. van Kuijk, Ronny M. Schnabel, Hugo ten Cate, Yvonne M. C. Henskens, Bas C. T. van Bussel |
40 |
[GO] |
2021―May―19 |
Prevalence and risk factors of thrombotic events on patients with COVID-19: a systematic review and meta-analysis |
Xiaoming Xiong, Jianhua Chi, Qinglei Gao |
41 |
[GO] |
2021―May―12 |
Giant intracardiac thrombosis in an infant with leukaemia and prolonged COVID-19 viral RNA shedding: a case report |
Ehsan Aghaei Moghadam, Shima Mahmoudi, Alieh Safari Sharari, Mehrnoush Afsharipour, Mojtaba Gorji, Amene Navaeian, et al. (+2) Azin Ghamari, Setareh Mamishi |
42 |
[GO] |
2021―Apr―20 |
An evaluation of venous thromboembolism by whole-body enhanced CT scan for critical COVID-19 pneumonia with markedly rises of coagulopathy related factors: a case series study |
Fumihiro Ogawa, Yasufumi Oi, Kento Nakajima, Reo Matsumura, Tomoki Nakagawa, Takao Miyagawa, et al. (+2) Takeru Abe, Ichiro Takeuchi |
43 |
[GO] |
2021―Mar―09 |
Proximal deep vein thrombosis and pulmonary embolism in COVID-19 patients: a systematic review and meta-analysis |
Gregoire Longchamp, Sara Manzocchi-Besson, Alban Longchamp, Marc Righini, Helia Robert-Ebadi, Marc Blondon |
44 |
[GO] |
2021―Mar―08 |
Low incidence of venous thrombosis but high incidence of arterial thrombotic complications among critically ill COVID-19 patients in Singapore |
Chuen Wen Tan, Bingwen Eugene Fan, Winnie Z. Y. Teo, Moon Ley Tung, Humaira Shafi, Dheepa Christopher, et al. (+21) Shuwei Zheng, Wee Ming Peh, Stephrene Seok Wei Chan, Vanessa Cui Lian Chong, Christian Aledia Gallardo, Cheng Chieh Ray Chang, Li Min Ling, Jing Yuan Tan, Ken Cheah Hooi Lee, Ghee Chee Phua, Benjamin Pei Zhi Cherng, Jenny Guek Hong Low, Vui Kian Ho, Vishnu Prasad, Lester Jung Long Wong, Cheryl Xiu Qi Lim, Yen Lin Chee, Kiat Hoe Ong, Lai Heng Lee, Heng Joo Ng, Eng Soo Yap |
45 |
[GO] |
2021―Mar―03 |
High rate of bleeding and arterial thrombosis in COVID-19: Saudi multicenter study |
Abdulrahman Al Raizah, Ahmed Al Askar, Naila Shaheen, Khalid Aldosari, Mohamed Alnahdi, Musumadi Luhanga, et al. (+9) Turki Alshuaibi, Wail Bajhmoum, Khaled Alharbi, Ghaida Alsahari, Hadeel Algahtani, Eunice Alrayes, Abdulrahim Basendwah, Alia Abotaleb, Mosaad Almegren |
46 |
[GO] |
2021―Feb―11 |
Pathological findings in rotation thromboelastometry associated with thromboembolic events in COVID-19 patients |
Kristina Boss, Andreas Kribben, Bartosz Tyczynski |
47 |
[GO] |
2021―Feb―10 |
Autopsy and statistical evidence of disturbed hemostasis progress in COVID-19: medical records from 407 patients |
Tiebin Jiang, Bo Lv, Hongxia Liu, Shiwen He, Guogang Zhang, Chanyi Li, et al. (+17) Wanqiong Li, Weilin Li, Yaqi He, Tong Zhang, Yunyun Wang, Wu Mo, Ning Yi, Luying Peng, Ying Li, Chunhong Ruan, Chengyuan Li, Yaqi Liu, Peipei Luo, Huan Jiang, Zhigang Xue, Liang Liu, Wenjun Wang |
48 |
[GO] |
2021―Jan―27 |
Possible involvement of Syndecan-1 in the state of COVID-19 related to endothelial injury |
Keiko Suzuki, Hideshi Okada, Hiroyuki Tomita, Kazuyuki Sumi, Yoshinori Kakino, Ryu Yasuda, et al. (+6) Yuichiro Kitagawa, Tetsuya Fukuta, Takahito Miyake, Shozo Yoshida, Akio Suzuki, Shinji Ogura |
49 |
[GO] |
2021―Jan―06 |
Fatal pulmonary arterial thrombosis in a COVID-19 patient, with asymptomatic history, occurred after swab negativization |
Franca Del Nonno, Daniele Colombo, Roberta Nardacci, Laura Falasca |
50 |
[GO] |
2020―Dec―29 |
Correction to: Incidence of thromboembolism in patients with COVID-19: a systematic review and meta-analysis |
Kochawan Boonyawat, Pichika Chantrathammachart, Pawin Numthavaj, Nithita Nanthatanti, Sithakom Phusanti, Angsana Phuphuakrat, et al. (+2) Pimjai Niparuck, Pantep Angchaisuksiri |
51 |
[GO] |
2020―Dec―15 |
Coagulation abnormalities in SARS-CoV-2 infection: overexpression tissue factor |
Zahra Eslamifar, Mahin Behzadifard, Masoud Soleimani, Saba Behzadifard |
52 |
[GO] |
2020―Dec―14 |
Suspected heparin-induced thrombocytopenia in a COVID-19 patient on extracorporeal membrane oxygenation support: a case report |
Xuan T. Phan, Tuan H. Nguyen, Tung T. Tran, Thu-Hien T. Huynh, Thuy-Ha T. Hoang, Vinh-Chau V. Nguyen, Thao N. T. Pham |
53 |
[GO] |
2020―Nov―23 |
Incidence of thromboembolism in patients with COVID-19: a systematic review and meta-analysis |
Kochawan Boonyawat, Pichika Chantrathammachart, Pawin Numthavej, Nithita Nanthatanti, Sithakom Phusanti, Angsana Phuphuakrat, et al. (+2) Pimjai Niparuck, Pantep Angchaisuksiri |
54 |
[GO] |
2020―Oct―16 |
Coagulopathy associated with COVID-19 - Perspectives & Preventive strategies using a biological response modifier Glucan |
Nobunao Ikewaki, Kosagi-Sharaf Rao, Armando Durant Archibold, Masaru Iwasaki, Rajappa Senthilkumar, Senthilkumar Preethy, et al. (+2) Shojiro Katoh, Samuel J. K. Abraham |
55 |
[GO] |
2020―Sep―10 |
Thrombotic events following tocilizumab therapy in critically ill COVID-19 patients: a Façade for prognostic markers |
Bassam Atallah, Wasim El Nekidy, Saad I. Mallah, Antoine Cherfan, Laila AbdelWareth, Jihad Mallat, Fadi Hamed |
56 |
[GO] |
2020―Sep―06 |
Management of the thrombotic risk associated with COVID-19: guidance for the hemostasis laboratory |
M. Hardy, T. Lecompte, J. Douxfils, S. Lessire, J. M. Dogné, B. Chatelain, et al. (+7) S. Testa, I. Gouin-Thibault, Y. Gruel, R. L. Medcalf, H. ten Cate, G. Lippi, F. Mullier |
57 |
[GO] |
2020―Sep―02 |
SARS-CoV-2 and pulmonary embolism: who stole the platelets? |
Michael Tran, Chirag Sheth, Rohan Bhandari, Scott J. Cameron, Deborah Hornacek |
58 |
[GO] |
2020―Apr―20 |
Thrombosis management in times of COVID-19 epidemy; a Dutch perspective |
Hugo ten Cate |